Some interesting points. More later
1/ revenue likely in 27
2/some important info drops remain for 23, adoa and 4th drug(10B rev), the first is imminent.
3/efficacy readouts possible before 26 but very “uncertain” so many factors.
Ann: Q3 Investor Call 27 September 2023, page-12
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.5¢ | $110.9K | 937.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 299768 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 129437 | 4 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |